Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 217

1.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.

Brar S, Ye F, James MT, Hemmelgarn B, Klarenbach S, Pannu N; Interdisciplinary Chronic Disease Collaboration .

JAMA Intern Med. 2018 Oct 27. doi: 10.1001/jamainternmed.2018.4749. [Epub ahead of print]

PMID:
30422153
2.

Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.

Przech S, Garg AX, Arnold JB, Barnieh L, Cuerden MS, Dipchand C, Feldman L, S Gill J, Karpinski M, Knoll G, Lok C, Miller M, Monroy M, Nguan C, Prasad GVR, Sarma S, Sontrop JM, Storsley L, Klarenbach S; Donor Nephrectomy Outcomes Research (DONOR) Network.

J Am Soc Nephrol. 2018 Nov 7. pii: ASN.2018040398. doi: 10.1681/ASN.2018040398. [Epub ahead of print]

PMID:
30404908
3.

Dialysis Modalities for the Treatment of End-Stage Kidney Disease: A Health Technology Assessment [Internet].

Sinclair A, Cimon K, Loncar M, Sood M, Komenda P, Severn M, Klarenbach S, So H, Tsoi B, Quinn R, Pauly R, Tonelli M, Manns B, Rader T, Moulton K, Moulton K, Helis E, Crain J, Pullman D.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Mar.

4.

Barriers and facilitators for implementation of electronic consultations (eConsult) to enhance specialist access to care: a scoping review protocol.

Osman MA, Schick-Makaroff K, Thompson S, Featherstone R, Bialy L, Kurzawa J, Okpechi IG, Habib S, Shojai S, Jindal K, Klarenbach S, Bello AK.

BMJ Open. 2018 Sep 28;8(9):e022733. doi: 10.1136/bmjopen-2018-022733.

5.

Follow-up Care of Living Kidney Donors in Alberta, Canada.

Lam NN, Lentine KL, Hemmelgarn B, Klarenbach S, Quinn RR, Lloyd A, Gourishankar S, Garg AX.

Can J Kidney Health Dis. 2018 Jul 26;5:2054358118789366. doi: 10.1177/2054358118789366. eCollection 2018.

6.

Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.

Habbous S, Sarma S, Barnieh LJ, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Aug;102(8):1367-1374. doi: 10.1097/TP.0000000000002222.

PMID:
30044364
7.

Hospitalizations in Dialysis Patients in Canada: A National Cohort Study.

Molnar AO, Moist L, Klarenbach S, Lafrance JP, Kim SJ, Tennankore K, Perl J, Kappel J, Terner M, Gill J, Sood MM.

Can J Kidney Health Dis. 2018 Jun 1;5:2054358118780372. doi: 10.1177/2054358118780372. eCollection 2018.

8.

Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.

Kadatz M, Klarenbach S, Gill J, Gill JS.

Am J Transplant. 2018 Oct;18(10):2457-2464. doi: 10.1111/ajt.14929. Epub 2018 Jun 14.

PMID:
29797402
9.

Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings.

Wilson BJ, Courage S, Bacchus M, Dickinson JA, Klarenbach S, Jaramillo Garcia A, Sims-Jones N, Thombs BD; Canadian Task Force on Preventive Health Care.

CMAJ. 2018 May 14;190(19):E588-E594. doi: 10.1503/cmaj.171430. No abstract available.

10.

Health care costs for the evaluation, surgery, and follow-up care of living kidney donors.

Habbous S, Sarma S, Barnieh L, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002222. [Epub ahead of print]

PMID:
29677068
11.

Validation of Living Donor Nephrectomy Codes.

Lam NN, Lentine KL, Klarenbach S, Sood MM, Kuwornu PJ, Naylor KL, Knoll GA, Kim SJ, Young A, Garg AX.

Can J Kidney Health Dis. 2018 Apr 9;5:2054358118760833. doi: 10.1177/2054358118760833. eCollection 2018.

12.

Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):907-915. doi: 10.2215/CJN.11451017. Epub 2018 Mar 29.

PMID:
29599300
13.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Oct;72(4):483-498. doi: 10.1053/j.ajkd.2018.01.036. Epub 2018 Mar 24.

14.

A population-based cohort study defines prognoses in severe chronic kidney disease.

Tonelli M, Wiebe N, James MT, Klarenbach SW, Manns BJ, Ravani P, Strippoli GFM, Hemmelgarn BR; Alberta Kidney Disease Network.

Kidney Int. 2018 May;93(5):1217-1226. doi: 10.1016/j.kint.2017.12.013. Epub 2018 Mar 7.

PMID:
29525394
15.
16.

Health care costs associated with hospital acquired complications in patients with chronic kidney disease.

Bohlouli B, Jackson T, Tonelli M, Hemmelgarn B, Klarenbach S.

BMC Nephrol. 2017 Dec 28;18(1):375. doi: 10.1186/s12882-017-0784-2.

17.

Catheter-related blood stream infections in hemodialysis patients: a prospective cohort study.

Thompson S, Wiebe N, Klarenbach S, Pelletier R, Hemmelgarn BR, Gill JS, Manns BJ, Tonelli M; Alberta Kidney Disease Network.

BMC Nephrol. 2017 Dec 8;18(1):357. doi: 10.1186/s12882-017-0773-5.

18.

Direct and indirect costs incurred by Australian living kidney donors.

Barnieh L, Kanellis J, McDonald S, Arnold J, Sontrop JM, Cuerden M, Klarenbach S, Garg AX, Boudville N; Donor Nephrectomy Outcomes Research (DONOR) Network.

Nephrology (Carlton). 2017 Dec 7. doi: 10.1111/nep.13205. [Epub ahead of print]

PMID:
29215180
19.

The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practice.

Barbour S, Lo C, Espino-Hernandez G, Sajjadi S, Feehally J, Klarenbach S, Gill J.

Nephrol Dial Transplant. 2017 Jul 2. doi: 10.1093/ndt/gfx185. [Epub ahead of print]

PMID:
29106654
20.

Health Care Costs Associated with AKI.

Collister D, Pannu N, Ye F, James M, Hemmelgarn B, Chui B, Manns B, Klarenbach S; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1733-1743. doi: 10.2215/CJN.00950117. Epub 2017 Oct 19.

21.

Serum 25-Hydroxyvitamin D Concentrations and Indicators of Mental Health: An Analysis of the Canadian Health Measures Survey.

Chu F, Ohinmaa A, Klarenbach S, Wong ZW, Veugelers P.

Nutrients. 2017 Oct 13;9(10). pii: E1116. doi: 10.3390/nu9101116.

22.

Concentrations of Trace Elements in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Am J Kidney Dis. 2017 Nov;70(5):696-704. doi: 10.1053/j.ajkd.2017.06.029. Epub 2017 Aug 31.

PMID:
28838766
23.

A Scoping Review for Strategies to Increase Living Kidney Donation.

Barnieh L, Collister D, Manns B, Lam NN, Shojai S, Lorenzetti D, Gill JS, Klarenbach S.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1518-1527. doi: 10.2215/CJN.01470217. Epub 2017 Aug 17. Review.

24.

Multimorbidity, dementia and health care in older people:a population-based cohort study.

Tonelli M, Wiebe N, Straus S, Fortin M, Guthrie B, James MT, Klarenbach SW, Tam-Tham H, Lewanczuk R, Manns BJ, Quan H, Ronksley PE, Sargious P, Hemmelgarn B; Alberta Kidney Disease Network.

CMAJ Open. 2017 Aug 14;5(3):E623-E631. doi: 10.9778/cmajo.20170052.

25.

Quality Assurance Audit of Technique Failure and 90-Day Mortality after Program Discharge in a Canadian Home Hemodialysis Program.

Shah N, Reintjes F, Courtney M, Klarenbach SW, Ye F, Schick-Makaroff K, Jindal K, Pauly RP.

Clin J Am Soc Nephrol. 2017 Jul 24. pii: CJN.00140117. doi: 10.2215/CJN.00140117. [Epub ahead of print]

26.

Adverse Outcomes Associated with Preventable Complications in Hospitalized Patients with CKD.

Bohlouli B, Jackson TJ, Tonelli M, Hemmelgarn B, Klarenbach S.

Clin J Am Soc Nephrol. 2017 May 8;12(5):799-806. doi: 10.2215/CJN.09410916. Epub 2017 Apr 27.

27.

Recommendations on hepatitis C screening for adults.

Grad R, Thombs BD, Tonelli M, Bacchus M, Birtwhistle R, Klarenbach S, Singh H, Dorais V, Holmes NM, Martin WK, Rodin R, Jaramillo Garcia A; Canadian Task Force on Preventive Health Care.

CMAJ. 2017 Apr 24;189(16):E594-E604. doi: 10.1503/cmaj.161521. No abstract available.

28.

Association of Preference-Based Health-Related Quality of Life with Weight Loss in Obese Adults.

Lester EL, Padwal R, Majumdar SR, Ye F, Birch DW, Klarenbach SW.

Value Health. 2017 Apr;20(4):694-698. doi: 10.1016/j.jval.2016.04.016. Epub 2016 Jun 28.

29.

Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.

Lam NN, Tonelli M, Lentine KL, Hemmelgarn B, Ye F, Wen K, Klarenbach S.

Kidney Int. 2017 Aug;92(2):470-478. doi: 10.1016/j.kint.2017.01.028. Epub 2017 Mar 31.

PMID:
28366228
30.

Choosing Wisely: The Canadian Society of Nephrology's List of 5 Items Physicians and Patients Should Question.

Chan E, Hemmelgarn B, Klarenbach S, Manns B, Mustafa R, Nesrallah G, McQuillan R.

Can J Kidney Health Dis. 2017 Feb 28;4:2054358117695570. doi: 10.1177/2054358117695570. eCollection 2017.

31.

Patient and provider perspectives on the design and implementation of an electronic consultation system for kidney care delivery in Canada: a focus group study.

Bello AK, Molzahn AE, Girard LP, Osman MA, Okpechi IG, Glassford J, Thompson S, Keely E, Liddy C, Manns B, Jinda K, Klarenbach S, Hemmelgarn B, Tonelli M.

BMJ Open. 2017 Mar 2;7(3):e014784. doi: 10.1136/bmjopen-2016-014784.

32.

The evaluating self-management and educational support in severely obese patients awaiting multidisciplinary bariatric care (EVOLUTION) trial: principal results.

Padwal RS, Klarenbach S, Sharma AM, Fradette M, Jelinski SE, Edwards A, Majumdar SR.

BMC Med. 2017 Mar 2;15(1):46. doi: 10.1186/s12916-017-0808-6.

33.

Providing Coverage for the Unique Lifelong Health Care Needs of Living Kidney Donors Within the Framework of Financial Neutrality.

Gill JS, Delmonico F, Klarenbach S, Capron AM.

Am J Transplant. 2017 May;17(5):1176-1181. doi: 10.1111/ajt.14147. Epub 2017 Jan 9.

34.

A new model to predict acute kidney injury requiring renal replacement therapy after cardiac surgery.

Pannu N, Graham M, Klarenbach S, Meyer S, Kieser T, Hemmelgarn B, Ye F, James M; APPROACH Investigators and the Alberta Kidney Disease Network.

CMAJ. 2016 Oct 18;188(15):1076-1083. Epub 2016 Jun 13.

35.

Assessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)-study protocol for a 2×2 factorial randomized trial.

Campbell DJ, Tonelli M, Hemmelgarn B, Mitchell C, Tsuyuki R, Ivers N, Campbell T, Pannu R, Verkerke E, Klarenbach S, King-Shier K, Faris P, Exner D, Chaubey V, Manns B; Interdisciplinary Chronic Disease Collaboration.

Implement Sci. 2016 Sep 26;11(1):131.

36.

Trends and Regional Variation in Hospital Mortality, Length of Stay and Cost in Hospital of Ischemic Stroke Patients in Alberta Accompanying the Provincial Reorganization of Stroke Care.

Ohinmaa A, Zheng Y, Jeerakathil T, Klarenbach S, Häkkinen U, Nguyen T, Friesen D, Ruseski J, Kaul P, Ariste R, Jacobs P.

J Stroke Cerebrovasc Dis. 2016 Dec;25(12):2844-2850. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.046. Epub 2016 Sep 20.

PMID:
27663512
37.

Randomised factorial mixed method pilot study of aerobic and resistance exercise in haemodialysis patients: DIALY-SIZE!

Thompson S, Klarenbach S, Molzahn A, Lloyd A, Gabrys I, Haykowsky M, Tonelli M.

BMJ Open. 2016 Sep 6;6(9):e012085. doi: 10.1136/bmjopen-2016-012085.

38.

Extracellular fluid management and hypertension in urban dwelling versus rural dwelling hemodialysis patients.

Tonelli M, Lloyd A, Pannu N, Klarenbach S, Ravani P, Jindal K, MacRae J, Unsworth L, Manns B, Hemmelgarn B.

J Nephrol. 2018 Feb;31(1):103-110. doi: 10.1007/s40620-016-0337-y. Epub 2016 Aug 23.

PMID:
27553110
39.

Statin Use and Survival After Acute Kidney Injury.

Brar S, Ye F, James M, Hemmelgarn B, Klarenbach S, Pannu N.

Kidney Int Rep. 2016 Aug 20;1(4):279-287. doi: 10.1016/j.ekir.2016.08.009. eCollection 2016 Nov.

40.

Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial.

Padwal R, McAlister FA, Wood PW, Boulanger P, Fradette M, Klarenbach S, Edwards AL, Holroyd-Leduc JM, Alagiakrishnan K, Rabi D, Majumdar SR.

JMIR Res Protoc. 2016 Jun 24;5(2):e107. doi: 10.2196/resprot.5775.

41.

A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support.

Nunes AJ, MacArthur RG, Kim D, Singh G, Buchholz H, Chatterley P, Klarenbach SW.

Value Health. 2016 Jun;19(4):494-504. doi: 10.1016/j.jval.2014.12.020. Review.

42.

Comparative effectiveness and safety of gastric bypass, sleeve gastrectomy and adjustable gastric banding in a population-based bariatric program: prospective cohort study.

Gill RS, Majumdar SR, Rueda-Clausen CF, Apte S, Birch DW, Karmali S, Sharma AM, Klarenbach S, Padwal RS.

Can J Surg. 2016 Aug;59(4):233-41. doi: 10.1503/cjs.013315.

43.

Impact of using two dialyzers in parallel on phosphate clearance in hemodialysis patients: a randomized trial.

Thompson S, Manns B, Lloyd A, Hemmelgarn B, MacRae J, Klarenbach S, Unsworth L, Courtney M, Tonelli M.

Nephrol Dial Transplant. 2017 May 1;32(5):855-861. doi: 10.1093/ndt/gfw085.

PMID:
27190374
44.

Risk of Hospital-Acquired Complications in Patients with Chronic Kidney Disease.

Bohlouli B, Tonelli M, Jackson T, Hemmelgam B, Klarenbach S.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):956-63. doi: 10.2215/CJN.09450915. Epub 2016 May 12.

45.

Increasing the uptake of exercise programs in the dialysis unit: a protocol for a realist synthesis.

Thompson S, Clark A, Molzahn A, Klarenbach S, Tonelli M.

Syst Rev. 2016 Apr 21;5:67. doi: 10.1186/s13643-016-0224-6.

46.

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolic Events: Economic Evaluation [Internet].

Klarenbach S, Lee K, Boucher M, So H, Manns B, Tonelli M.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar.

47.

A Qualitative Study to Explore Patient and Staff Perceptions of Intradialytic Exercise.

Thompson S, Tonelli M, Klarenbach S, Molzahn A.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1024-33. doi: 10.2215/CJN.11981115. Epub 2016 Mar 29.

48.

Recommendations on screening for colorectal cancer in primary care.

Bacchus CM, Dunfield L, Gorber SC, Holmes NM, Birtwhistle R, Dickinson JA, Lewin G, Singh H, Klarenbach S, Mai V, Tonelli M; Canadian Task Force on Preventive Health Care.

CMAJ. 2016 Mar 15;188(5):340-8. doi: 10.1503/cmaj.151125. Epub 2016 Feb 22. No abstract available.

49.

Comorbidity as a driver of adverse outcomes in people with chronic kidney disease.

Tonelli M, Wiebe N, Guthrie B, James MT, Quan H, Fortin M, Klarenbach SW, Sargious P, Straus S, Lewanczuk R, Ronksley PE, Manns BJ, Hemmelgarn BR.

Kidney Int. 2015 Oct;88(4):859-66. doi: 10.1038/ki.2015.228. Epub 2015 Jul 29.

PMID:
26221754
50.

Healthcare Costs Attributable to Hypertension: Canadian Population-Based Cohort Study.

Weaver CG, Clement FM, Campbell NR, James MT, Klarenbach SW, Hemmelgarn BR, Tonelli M, McBrien KA; Alberta Kidney Disease Network and the Interdisciplinary Chronic Disease Collaboration.

Hypertension. 2015 Sep;66(3):502-8. doi: 10.1161/HYPERTENSIONAHA.115.05702. Epub 2015 Jul 13.

PMID:
26169049

Supplemental Content

Loading ...
Support Center